Sio Capital Management, LLC Spruce Biosciences, Inc. Transaction History

Sio Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$2.33 - $5.74 $1.41 Million - $3.46 Million	-603,027 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.01 - $11.26 $265,714 - $497,827	-44,212 Reduced 6.83%	603,027 $3.62 Million
Q2 2021 Aug 16, 2021	SELL	$10.12 - $17.46 $1.68 Million - $2.89 Million	-165,645 Reduced 20.38%	647,239 $7.26 Million
Q1 2021 May 14, 2021	BUY	$14.8 - $25.79 $2.61 Million - $4.54 Million	176,231 Added 27.68%	812,884 $13.5 Million
Q4 2020 Feb 16, 2021	BUY	$15.38 - $32.42 $9.79 Million - $20.6 Million	636,653 New	636,653 $15.5 Million

15.4M

16.7K

1.1K

Ticker SPRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,560,200
Market Cap $9.42M
Description
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which i...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.